novo nordisk zepbound - Search News

Order byBest matchMost fresh

News

Novo Nordisk, Lilly and Wegovy

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial. The data is the first head-to-head trial comparing the wildly popular medicines,

Continue reading

· 3d · on MSN

TipRanks on MSN · 3d

Eli Lilly’s Zepbound Defeats Novo Nordisk’s Wegovy Once Again

Novo Nordisk Tumbles as Lilly's Zepbound Shows Greater Weight Loss in Trial

1don MSN

Novo Nordisk Strikes $2.2 Billion Deal With Septerna to Develop New Obesity Treatments

COPENHAGEN (Reuters) -Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral ...

3don MSN

Here’s how much extra weight is lost with Zepbound over Wegovy

A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their ...

MarketBeat on MSN15h

Is It Time to Buy the Dip in Novo Nordisk Stock?

CompanyOverview|NYSE:NVO] Despite a double beat in its quarterly earnings on May 7, Novo Nordisk A/S (NYSE: NVO) stock is ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results